Sun Pharmaceuticals to invest in wind energy JV with SuzlonIllustrative image – not actual.

Sun Pharmaceuticals will invest Rs 400 crore in a 50:50 joint venture with Suzlon for setting up wind projects across India. In addition, it will also provide working capital for 1,200 MW over the next two years.


The company’s investment is over and above the Rs 1,800 crore shelled out earlier this year to buy a 23 per cent stake in Suzlon Energy. Suzlon will also invest Rs 400 crore by way of equity in the new JV. It will be set up this fiscal, and over the next two years it will develop multiple wind projects totalling 450-500 MW in four states.


Pune-based Suzlon Energy announced the completion of the sale of its wholly-owned subsidiary, Senvion SE, to US-based Centerbridge Partners. The transaction closure, which follows an agreement signed with Centerbridge in January 2015, has brought around Rs 7,000 crore of cash into Suzlon’s kitty.


 

← All latest storiesBack to top →